This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (funded, already peer-reviewed, non-eHealth) (172)

Published on in Vol 6, No 3 (2017): March

Innovations in the Management of Musculoskeletal Pain With Alpha-Lipoic Acid (IMPALA Trial): Study protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of Alpha-Lipoic Acid for the Treatment of Fibromyalgia Pain

Innovations in the Management of Musculoskeletal Pain With Alpha-Lipoic Acid (IMPALA Trial): Study protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of Alpha-Lipoic Acid for the Treatment of Fibromyalgia Pain

Innovations in the Management of Musculoskeletal Pain With Alpha-Lipoic Acid (IMPALA Trial): Study protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of Alpha-Lipoic Acid for the Treatment of Fibromyalgia Pain

Authors of this article:

Ian Gilron1 Author Orcid Image ;   Dongsheng Tu1 Author Orcid Image ;   Ronald Holden1 Author Orcid Image ;   Tanveer Towheed1 Author Orcid Image ;   Dan Ziegler2 Author Orcid Image ;   Louie Wang1 Author Orcid Image ;   Roumen Milev1 Author Orcid Image ;   Christopher Gray3 Author Orcid Image
Article Authors Cited by (5) Tweetations (4) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.